Page last updated: 2024-08-16

ribavirin and Postoperative Complications

ribavirin has been researched along with Postoperative Complications in 96 studies

Research

Studies (96)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (3.13)	18.7374
1990's	9 (9.38)	18.2507
2000's	51 (53.13)	29.6817
2010's	31 (32.29)	24.3611
2020's	2 (2.08)	2.80

Authors

Authors	Studies
Alexander, BD; Arif, S; Miller, RA; Permpalung, N; Reynolds, JM; Saullo, JL; Thaniyavarn, T	1
Costa, J; Forns, X; García-López, M; Lens, S; Navasa, M; Pérez-Del-Pulgar, S; Sastre, L	1
Bolewska, B; Buivydiene, A; Durlik, M; Flisiak, R; Jabłkowski, M; Jakutiene, J; Karpińska, E; Karwowska, KM; Katzarov, K; Kupcinskas, L; Pisula, A; Rostkowska, K; Simonova, M; Tolmane, I; Tronina, O; Wawrzynowicz-Syczewska, M	1
Garcia, B; Johnson, K; Salgado, J; Sharma, N; Wille, K	1
Adragão, T; Birne, R; Bruges, M; Carvalho, L; Chagas, C; Jorge, C; Lebre, L; Machado, D; Matias, P; Nascimento, C; Querido, S; Weigert, A	1
Bandeira de Mello Brandao, A; Costabeber, AM; Cracco Cantisani, GP; Kiss, G; Leipnitz, I; Marroni, CA; Martini, J; Medeiros Fleck, A; Meine, MH; Mucenic, M; Sacco, FKF; Soares Schlindwein, E; Zanotelli, ML	1
Häffner, K; Klämbt, V; Panning, M; Pohl, M; Seidl, M	1
Drinane, M; Jing Wang, X; Watt, K	1
Baumann, U; Goldschmidt, I; Junge, N; Manns, M; Pfister, ED; Pischke, S; Wedemeyer, H	1
Everson, GT; Reddy, KR	1
Gerken, G; Herzer, K; Jochum, C; Papadopoulos-Köhn, A; Paul, A; Timm, J	1
Fernández-Alonso, R; González-Diéguez, ML; Junceda-Moreno, J; Pérez-Carro, G; Rodríguez-García, M	1
Dekio, F; Malik, S; Wen, JW	1
Fridell, JA; Ghabril, M; Joseph Tector, A; Kwo, PY; Lacerda, MA; Vianna, R	1
Aqel, B; Chervenak, AE; Henry, TM; Keaveny, AP; Leise, M; Murphy, JL; Pungpapong, S; Ryland, K; Vargas, HE; Watt, KD; Werner, KT	1
Eguchi, S; Hidaka, M; Kuroki, T; Miyaaki, H; Nakao, K; Soyama, A; Takatsuki, M; Yamashita, M	1
Benzimra, M; Burrows, FS; Carlos, LM; Glanville, AR; Havryk, AP; Malouf, MA; Marriott, DJ; Plit, ML	1
Chewaproug, D; Knorr, JP; Neeli, S; Torres, E; Zaki, R	1
Coilly, A; Duclos-Vallée, JC; Roche, B; Samuel, D	1
Cho, WH; Han, SY; Hyun, SK; Kim, HT; Park, UJ	1
Achterfeld, A; Canbay, A; Gerken, G; Herzer, K; Papadopoulos-Köhn, A; Paul, A; Timm, J; Walker, A	1
Dienes, HP; Galante, A; Gisa, A; Hiller, J; Lohse, AW; Luetgehethmann, M; Nashan, B; Pischke, S; Polywka, S; Sterneck, M; Suneetha, PV	1
Bau, S; Busuttil, RW; Durazo, F; El Kabany, M; Goo, T; Han, S; Jimenez, M; Kaldas, F; Saab, S; Tong, MJ; Zhao, D	1
Diago, M; Peño, L; Plana, L; Urquijo, JJ	1
Durlik, M; Hreńczuk, M; Kosieradzki, M; Małkowski, P; Pacholczyk, M; Sowińska, R; Tronina, O	1
Appolo, B; Bloom, R; Patel, N; Sawinski, D	1
Acevedo, P; Bernal Blanco, G; Gentil Govantez, MA; Gonzalez Roncero, FM; Gonzalez-Corvillo, C; Perez Valdivia, MA; Sousa, JM; Suarez Benjumea, A; Suñer Poblet, M	1
Alonso, A; Franco, A; Gentil, MA; González-Corvillo, C; Hernández-Marrero, D; Jiménez-Martín, C; Lauzurica, LR; Perelló, M; Sánchez-Fructuoso, A; Zarraga, S	1
Egawa, H; Haga, H; Ito, T; Takada, Y; Tanaka, K; Ueda, Y; Uemoto, S	1
Anselmo, M; De Leo, P; Grasso, A; Malfatti, F; Menardo, G; Toscanini, F	1
Force, SD; Foster, M; Gal, AA; Lawrence, EC; Lyon, GM; Mitchell, PO; Naik, PM; Neujahr, DC; Pelaez, A; Ramirez, AM	1
Fiel, MI; Schiano, T	1
Carrión, JA; Crespo, G; Forns, X; García-Valdecasas, JC; Martínez-Bauer, E; Navasa, M; Pérez-del-Pulgar, S; Ramírez, S	1
Higaki, K; Ide, T; Karashima, T; Maeyama, Y; Narita, K; Okamura, S; Sakai, T; Sata, M; Sumie, H; Yoshikai, H	1
Agoglia, L; Balbi, E; Cariús, LP; Covelo, MC; Enne, M; Gonzalez, AC; Leal, CR; Oliveira, PV; Pacheco-Moreira, LF; Pousa, FS; Roma, J	1
Ahya, SN; Baker, T; Levitsky, J; Norvell, JP; Van Wagner, LB; Wang, E	1
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S	1
Almerighi, C; Angelico, M; Anselmo, A; De Luca, L; Lenci, I; Lionetti, R; Monaco, A; Palmieri, G; Tariciotti, L; Tisone, G	1
Askar, M; Avery, R; Corey, R; Eghtesad, B; Fung, J; Lopez, R; Miller, C; Pidwell, D; Thomas, D; Zein, NN	1
Bailly, F; Trepo, C	1
Fukuhara, T; Gion, T; Ikegami, T; Maehara, Y; Morita, K; Nagata, S; Soejima, Y; Sugimachi, K; Takeishi, K; Taketomi, A; Toshima, T; Umeda, K	1
Roche, B; Samuel, D	3
Barbui, A; Bobbio, A; David, E; Fadda, M; Franchello, A; Lavezzo, B; Ottobrelli, A; Rizzetto, M; Salizzoni, M; Smedile, A; Torrani, M; Zamboni, F	1
Bizollon, T; Trepo, C	1
Feray, C; Roche, B; Samuel, D	1
Samuel, D	1
Balan, V; Brass, C; Conjeevaram, H; Crippin, J; Demetris, AJ; Gish, R; Kwo, P; McGuire, B; Rakela, J; Shakil, AO; Teperman, L; Wright, TL	1
Boas, LS; da Rocha, IF; Dulley, FL; Machado, CM; Mendes, AV; Pannuti, CS; Santos, MF; Sturaro, D	1
Dummer, S; McCurdy, LH; Milstone, A	1
Beckebaum, S; Broelsch, CE; Cicinnati, VR; Dirsch, O; Erim, Y; Frilling, A; Gerken, G; Karliova, M; Malago, M; Treichel, U	1
Boeckh, M; Corey, L; Peck, AJ	1
Berenguer, J; Berenguer, M; Calvo, F; Carrasco, D; Palau, A; Prieto, M; Rayón, JM	1
Fredrick, RT; Hassanein, TI	1
Adham, M; Baulieux, J; Bizollon, T; Chevallier, M; Ducerf, C; Pradat, P; Trepo, C; Zoulim, F	1
Boulestin, A; Chatelut, E; Durand, D; Esposito, L; Izopet, J; Kamar, N; Rostaing, L; Sandres-Saune, K; Selves, J; Stébenet, M	1
Filipović, R; Lavrnja, I; Nedeljković, N; Peković, S; Rakić, L; Stojiljković, M; Stojkov, D; Subasić, S	1
Aboyoun, CL; Carter, IW; Glanville, AR; Malouf, MA; Morton, JM; Plit, ML; Scott, AI	1
Bejarano, PA; Casanova-Romero, PY; Martinez, EJ; Mindikoglu, AL; Regev, A; Schiff, ER; Tzakis, AG	1
Makuuchi, M; Sugawara, Y	2
Dixit, V; Fabrizi, F; Lunghi, G; Martin, P	1
Asselah, T; Belghiti, J; Boudjema, H; Durand, F; Francoz, C; Marcellin, P; Sobesky, R; Valla, D	1
Barreiros, AP; Biesterfeld, S; Böcher, WO; Galle, PR; Greif-Higer, G; Kanzler, S; Lohse, AW; Mönch, C; Otto, G; Schuchmann, M; Sprinzl, MF; Wörns, MA; Zimmermann, A; Zimmermann, T	1
Bosco, G; de Gennaro, M; Fiorini, I; Luchi, S; Meini, M; Moneta, S; Ricciardi, L; Scasso, A	1
Busuttil, RW; Durazo, F; Farmer, DG; Ghobrial, RM; Goldstein, LI; Han, S; Ibrahim, AB; Oh, MK; Saab, S; Tong, MJ; Yersiz, H	1
Dzierzanowska-Fangrat, K; Jankowska, I; Kaliciński, P; Kluge, P; Pawłowska, J; Socha, J; Teisseyre, J; Teisseyre, M; Woynarowski, M	1
Crespo, M; Husain, S; Ismailjee, SB; Kwak, EJ; McCurry, KR; Paterson, DL; Pilewski, JM; Raza, K; Rinaldo, CR; Sanghavi, S; Studer, SM	1
Embrey, RP; Geist, LJ	1
Chevallier, P; Chossegros, P; Daoud, S; Dubernard, JM; Garnier, JL; Touraine, JL	1
Carre, P; Didier, A; Henry, S; Icart, J; Leophonte, P; Murris-Espin, M	1
Cobian, L; Greene, J; Houston, S; Sinnott, JT	1
Adahm, M; Baulieux, J; Bizollon, T; Ducerf, C; Trepo, C	1
Bowden, RA; Crawford, SW; Lewinsohn, DM; Mattson, D	1
Hug, B	1
al-Muzairai, IM; Costandi, JN; Gupta, RK; Johny, KV; Mousawi, M; Nampoory, MR; Ninan, VT; Samhan, M	1
Champlin, RE; Englund, J; Ghosh, S; Giralt, SA; Ippoliti, C; Jacobson, K; Mallik, S; Neumann, J; Raad, I; Rolston, K; Whimbey, E	1
Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Tur-Kaspa, R	1
Braun, F; Ramadori, G; Ringe, B; Wietzke, P	1
Bastani, B; Philipneri, M	1
Berk, BS; Chou, S; Corless, CL; Gopal, DV; Olyaei, A; Orloff, SL; Rabkin, JM; Rosen, HR	1
Davis, L; De Vera, ME; Heffron, TG; Martinez, E; Rosado, K; Sharma, S; Smallwood, GA; Stieber, AC	1
Balauff, A; Buckels, J; Kelly, D; McKiernan, P; Pearman, K; Sira, J	1
Goodman, Z; Gramlich, T; Mayes, J; Ong, JP; Sarbah, S; Yen-Lieberman, B; Younossi, ZM	1
Ashur, Y; Bishara, A; Eid, A; Galun, E; Ilan, Y; Israeli, E; Jurim, O; Safadi, R	1
Airoldi, A; Alberti, AB; Belli, LS; Cernuschi, A; D'Amico, M; de Carlis, L; Forti, D; Minola, E; Pinzello, G; Rondinara, G; Vangeli, M	1
Pol, S	1
Burgart, LJ; Charlton, M; El-Amin, OM; Kremers, WK; Narayanan Menon, KV; Poterucha, JJ; Rosen, CB; Wiesner, RH	1
Barrera, JM; Campistol, JM; Esforzado, N; Morales, JM	1
Baguet, JC; Beytout, D; Deteix, P; Gazuy, N; Mignot, P; Peigue-Lafeuille, H	1
Dunn, SP; Herzog, KD; Langham, MR; Marmon, LM	1
Andersson, J; Aschan, J; Forsgren, M; Lewensohn-Fuchs, I; Ljungman, P; Ringdén, O	1
Balfour, HH; Dehner, LP; Englund, JA; Jordan, MC; Sullivan, CJ; Vercellotti, GM	1

Reviews

13 review(s) available for ribavirin and Postoperative Complications

Article	Year
Management of post transplant hepatitis C in the direct antiviral agents era. Hepatology international, 2015, Volume: 9, Issue:2 Topics: Antiviral Agents; Carbamates; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Liver Transplantation; Oligopeptides; Postoperative Complications; Proline; Protease Inhibitors; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Valine; Viral Nonstructural Proteins	2015
Hepatitis C virus treatment pre- and post-liver transplantation. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1 Topics: Antiviral Agents; Disease Progression; Drug Administration Schedule; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Proline; Recombinant Proteins; Recurrence; Ribavirin; Serine Proteinase Inhibitors; Time Factors; Viral Load	2012
Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months? Journal of hepatology, 2002, Volume: 37, Issue:2 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin	2002
[Treatment of hepatitis C after liver transplantation]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Acute Disease; Animals; Drug Therapy, Combination; Follow-Up Studies; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunoglobulins; Immunosuppression Therapy; Interferons; Liver Transplantation; Pan troglodytes; Postoperative Care; Postoperative Complications; Preoperative Care; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Virus Replication	2002
Role of growth factors in the treatment of patients with HIV/HCV coinfection and patients with recurrent hepatitis C following liver transplantation. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1 Suppl Topics: Antiviral Agents; Growth Substances; Hematologic Diseases; Hematopoiesis; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin; United States	2005
Aspects of hepatitis C virus infection relating to liver transplantation. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:4 Topics: Antiviral Agents; Graft Survival; Hepatitis C, Chronic; Humans; Interferons; Liver Transplantation; Postoperative Complications; Ribavirin; Secondary Prevention	2006
Living donor liver transplantation to patients with hepatitis C virus cirrhosis. World journal of gastroenterology, 2006, Jul-28, Volume: 12, Issue:28 Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Liver Transplantation; Living Donors; Postoperative Complications; Recombinant Proteins; Ribavirin; Risk Factors; Secondary Prevention; Tissue and Organ Procurement	2006
Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Alimentary pharmacology & therapeutics, 2006, Nov-15, Volume: 24, Issue:10 Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferons; Kidney Transplantation; Postoperative Complications; Ribavirin; Treatment Outcome	2006
[Hepatitis C and liver transplantation: fibrosis progression and treatment. Or how to improve management]. Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:11 Topics: Antiviral Agents; Disease Progression; Drug Therapy, Combination; Graft Rejection; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Ribavirin; Secondary Prevention; Treatment Outcome	2006
New approaches to treatment of recurrent hepatitis C virus following liver transplantation using ribavirin. Transplantation proceedings, 1996, Volume: 28, Issue:5 Topics: Adult; Antiviral Agents; Diagnosis, Differential; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral	1996
Kidney disease in patients with chronic hepatitis C. Current gastroenterology reports, 2001, Volume: 3, Issue:1 Topics: Antigen-Antibody Complex; Antiviral Agents; Disease Progression; Glomerulonephritis; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Postoperative Complications; Recurrence; Ribavirin; Treatment Outcome	2001
[HVB and HVC infections in nephrology]. Nephrologie, 2001, Volume: 22, Issue:6 Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia	2001
[Kidney transplantation in patients positive for hepatitis C virus]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22 Suppl 5 Topics: Algorithms; Antiviral Agents; Cross Infection; Follow-Up Studies; Glomerulonephritis; Graft Survival; Hepatitis C; Humans; Interferons; Kidney Diseases; Kidney Transplantation; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Prevalence; Renal Dialysis; Retrospective Studies; Ribavirin; RNA, Viral; Spain; Survival Analysis; Tissue Donors; Treatment Outcome; Waiting Lists	2002

Trials

10 trial(s) available for ribavirin and Postoperative Complications

Article	Year
Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant. Clinical transplantation, 2014, Volume: 28, Issue:6 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Prognosis; Recombinant Proteins; Recurrence; Retreatment; Ribavirin; Risk Factors; Viral Load	2014
Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:7 Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Living Donors; Male; Middle Aged; Pilot Projects; Plasmapheresis; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Viral Load	2008
Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin. Journal of hepatology, 2002, Volume: 37, Issue:2 Topics: Adult; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Predictive Value of Tests; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome	2002
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5 Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Patient Dropouts; Pilot Projects; Postoperative Complications; Recurrence; Ribavirin; Treatment Outcome	2002
Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C. Transplantation, 2005, Feb-15, Volume: 79, Issue:3 Topics: Adult; Amantadine; Antiviral Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Survival Analysis	2005
Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:12 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	2005
[Preliminary results and complications of HCV treatment after liver transplantation]. Przeglad epidemiologiczny, 2006, Volume: 60, Issue:4 Topics: Adolescent; Adult; Antiviral Agents; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Treatment Outcome	2006
Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Humans; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin	1996
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone marrow transplantation, 2000, Volume: 25, Issue:7 Topics: Adult; Aerosols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Pilot Projects; Pneumonia, Viral; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin; Transfusion Reaction; Transplantation, Autologous; Transplantation, Homologous	2000
Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Adult; Aged; Antiviral Agents; Cause of Death; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Survival Rate; Time Factors; Treatment Outcome	2000

Other Studies

73 other study(ies) available for ribavirin and Postoperative Complications

Article	Year
Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients. Transplantation, 2020, Volume: 104, Issue:6 Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Antiviral Agents; Female; Forced Expiratory Volume; Humans; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Oxygen; Postoperative Complications; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; RNA, Viral; Transplant Recipients; Treatment Outcome	2020
The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy. Gastroenterologia y hepatologia, 2020, Volume: 43, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Common Variable Immunodeficiency; Drug Therapy, Combination; Fatal Outcome; Focal Nodular Hyperplasia; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Kidney Transplantation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir	2020
Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study. Annals of transplantation, 2017, Apr-07, Volume: 22 Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Postoperative Complications; Proline; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine	2017
Clinical Outcomes of Paramyxovirus Infections in Lung Transplant Recipients Treated With Oral Ribavirin: A Two-Center Case Series. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2019, Volume: 17, Issue:3 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Paramyxoviridae Infections; Postoperative Complications; Retrospective Studies; Ribavirin; Treatment Outcome	2019
Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal. Transplantation proceedings, 2018, Volume: 50, Issue:3 Topics: Adult; Antiviral Agents; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Portugal; Postoperative Complications; Retrospective Studies; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response	2018
Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study. Transplantation proceedings, 2018, Volume: 50, Issue:3 Topics: Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine	2018
Ribavirin therapy of hepatitis E infection may cause hyporegenerative anemia in pediatric renal transplant patients. Pediatric transplantation, 2018, Volume: 22, Issue:4 Topics: Adolescent; Anemia; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Humans; Kidney Transplantation; Postoperative Complications; Ribavirin	2018
Sofosbuvir and Ribavirin Eradication of Refractory Hepatitis E in an Immunosuppressed Kidney Transplant Recipient. Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:5 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis E; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Ribavirin; Sofosbuvir	2019
Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatric transplantation, 2013, Volume: 17, Issue:4 Topics: Adolescent; Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hepatitis; Hepatitis E; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Liver Failure; Liver Transplantation; Male; Polymerase Chain Reaction; Postoperative Complications; Retrospective Studies; Ribavirin; RNA, Viral	2013
Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation. Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:3 Topics: Antiviral Agents; Drug Interactions; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Proline; Protease Inhibitors; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Treatment Outcome	2013
[HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:36 Topics: Adult; Antiviral Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load	2013
[Interferon-alpha toxicity and reversible bilateral optical neuropathy: a timely withdrawal of the drug]. Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:4 Topics: Adult; Evoked Potentials, Visual; Factor VII Deficiency; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Optic Neuritis; Polyethylene Glycols; Postoperative Complications; Reaction Time; Recombinant Proteins; Ribavirin; Vision Disorders	2014
Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir. Pediatric transplantation, 2014, Volume: 18, Issue:2 Topics: Adolescent; Carcinoma, Hepatocellular; Child; Graft Survival; Hepatitis C; Humans; Interferons; Liver Neoplasms; Liver Transplantation; Male; Polyethylene Glycols; Postoperative Complications; Proline; Recurrence; Ribavirin; Severe Combined Immunodeficiency	2014
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:6 Topics: Aged; Antiviral Agents; Female; Genotype; Hepatitis C; Heterocyclic Compounds, 3-Ring; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uridine Monophosphate	2015
[Overwhelming postsplenectomy infection during combination therapy with interferon ribavirin after living donor liver transplantation for hepatitis C: a case report]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2015, Volume: 112, Issue:2 Topics: Critical Care; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Liver Transplantation; Living Donors; Middle Aged; Pneumococcal Infections; Postoperative Complications; Recurrence; Ribavirin; Splenectomy	2015
Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2015, Volume: 34, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Female; Follow-Up Studies; Humans; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult	2015
Severe Interferon/Ribavirin-Induced Hyperuricemia and Urate Nephropathy Requiring Rasburicase and Hemodialysis in a Liver Transplant Recipient. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13, Issue:6 Topics: Female; Gout Suppressants; Humans; Hyperuricemia; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Middle Aged; Postoperative Complications; Recombinant Proteins; Ribavirin; Urate Oxidase	2015
Successful treatment of disseminated adenovirus infection with ribavirin and intravenous immunoglobulin in an adult renal transplant recipient: a case report. Transplantation proceedings, 2015, Volume: 47, Issue:3 Topics: Adenovirus Infections, Human; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Kidney Transplantation; Nephritis, Interstitial; Postoperative Complications; Ribavirin	2015
Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant. Digestion, 2015, Volume: 91, Issue:4 Topics: Antiviral Agents; Carbamates; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Valine; Viral Load; Viremia	2015
Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Hepatitis E; Hepatitis, Chronic; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Ribavirin; Treatment Outcome; Young Adult	2015
Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis. Clinical transplantation, 2015, Volume: 29, Issue:9 Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Cholestasis, Intrahepatic; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplantation; Male; Matched-Pair Analysis; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome	2015
Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis. Gastroenterologia y hepatologia, 2017, Volume: 40, Issue:5 Topics: Anemia, Hemolytic; Antiviral Agents; Bacteremia; Blood Component Transfusion; Catheter-Related Infections; Drug Therapy, Combination; Glomerulonephritis; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Renal Dialysis; Ribavirin; Staphylococcal Infections; Thrombocytopenia	2017
Nursing Problems in Care of a Patient with Very Early HCV Infection Recurrence After Liver Transplantation: A Case Report. Annals of transplantation, 2016, Jun-30, Volume: 21 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Liver Failure; Liver Transplantation; Oligopeptides; Postoperative Complications; Recurrence; Reoperation; Ribavirin; Sofosbuvir; Treatment Outcome; Young Adult	2016
Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation. Transplantation, 2017, Volume: 101, Issue:5 Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Female; Fluorenes; Follow-Up Studies; Hepatitis C, Chronic; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Time Factors; Tissue Donors; Treatment Outcome; Uridine Monophosphate	2017
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. Transplantation proceedings, 2016, Volume: 48, Issue:9 Topics: Adult; Antiviral Agents; Female; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Ribavirin; Sofosbuvir; Tacrolimus	2016
Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study. Transplantation proceedings, 2016, Volume: 48, Issue:9 Topics: Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppression Therapy; Kidney Transplantation; Lactams, Macrocyclic; Macrocyclic Compounds; Postoperative Complications; Proline; Prospective Studies; Pyrrolidines; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Spain; Sulfonamides; Treatment Outcome; Valine	2016
Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report Transplantation proceedings, 2008, Volume: 40, Issue:5 Topics: Adult; Antiviral Agents; Ascitic Fluid; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Mycobacterium tuberculosis; Pleural Effusion; Postoperative Complications; Ribavirin; Safety; Treatment Outcome; Tuberculosis	2008
Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:1 Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Infusions, Intravenous; Lung Transplantation; Male; Methylprednisolone Hemisuccinate; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Sarcoidosis; Time Factors	2009
Jaundice developing in a patient with hepatitis C4 months after liver transplantation. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:2 Topics: Antiviral Agents; Fatal Outcome; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Jaundice; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Tacrolimus	2009
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study. Journal of hepatology, 2009, Volume: 50, Issue:4 Topics: Adult; Aged; Antiviral Agents; Bacterial Infections; Carcinoma, Hepatocellular; Female; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Peritonitis; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Safety; Time Factors; Viral Load; Waiting Lists; Young Adult	2009
[Case of overwhelming postsplenectomy infection (OPSI) with chronic hepatitis type C during peginterferon/ribavirin combination therapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2009, Volume: 106, Issue:3 Topics: Antiviral Agents; Fatal Outcome; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Middle Aged; Neutropenia; Pneumococcal Infections; Pneumococcal Vaccines; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Sepsis; Splenectomy	2009
Treatment for recurrent hepatitis C virus infection after liver transplantation. Transplantation proceedings, 2009, Volume: 41, Issue:3 Topics: Antiviral Agents; Biopsy; Female; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; RNA, Viral; Viral Load	2009
Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. Journal of hepatology, 2009, Volume: 51, Issue:5 Topics: Antiviral Agents; Case-Control Studies; Female; Graft Survival; Hepatitis C; Humans; Interferon Type I; Kaplan-Meier Estimate; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Treatment Outcome	2009
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation. Transplantation proceedings, 2009, Volume: 41, Issue:7 Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole	2009
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:4 Topics: Antiviral Agents; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Ribavirin	2010
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:11 Topics: Antiviral Agents; Bacterial Infections; Drug Resistance, Viral; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Killer Cells, Natural; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Receptors, KIR; Receptors, KIR2DL2; Recombinant Proteins; Recurrence; Ribavirin	2009
Maintenance ribavirin monotherapy: the case for post-transplantation recurrent hepatitis C. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:4 Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin	2010
Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case. Surgery today, 2010, Volume: 40, Issue:10 Topics: Antiviral Agents; Biopsy; Cholangiography; Cholestasis, Intrahepatic; Diagnosis, Differential; Drug Carriers; Early Diagnosis; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; RNA, Viral; Ultrasonography, Doppler	2010
Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study. Transplantation, 2011, Aug-15, Volume: 92, Issue:3 Topics: Antiviral Agents; Cohort Studies; Cyclosporine; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Secondary Prevention	2011
I favor therapy for hepatitis C virus recurrence after transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1 Topics: Acute Disease; Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral	2002
[Recurrence after customary hepatitis C therapy. Those patients are now treatable, too]. MMW Fortschritte der Medizin, 2003, Feb-27, Volume: 145, Issue:9 Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Time Factors; Viral Load	2003
Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone marrow transplantation, 2003, Volume: 31, Issue:8 Topics: Acetamides; Aerosols; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Fluorescent Antibody Technique, Indirect; Hematologic Neoplasms; Humans; Influenza, Human; Oseltamivir; Paramyxoviridae Infections; Postoperative Complications; Respirovirus Infections; Ribavirin; Transplantation, Autologous; Transplantation, Homologous; Virus Shedding	2003
Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:7 Topics: Administration, Inhalation; Adult; Aged; Antiviral Agents; Bronchoalveolar Lavage; Combined Modality Therapy; Female; Forced Expiratory Volume; Graft Rejection; Humans; Immunosuppressive Agents; Lung Diseases; Lung Transplantation; Male; Middle Aged; Paramyxoviridae Infections; Polymerase Chain Reaction; Postoperative Complications; Prevalence; Retrospective Studies; Ribavirin; Seasons; Tennessee; Treatment Outcome	2003
Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection. Transplantation proceedings, 2003, Volume: 35, Issue:6 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2003
Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-01, Volume: 39, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Preoperative Care; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Outcome	2004
Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:11 Topics: Acute Disease; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; Treatment Outcome	2004
Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C. Journal of medical virology, 2005, Volume: 76, Issue:1 Topics: Adult; Aged; Anemia, Hemolytic; Antiviral Agents; Cytokines; Female; Hepatitis C, Chronic; Humans; Iron; Iron Overload; Kidney Transplantation; Liver; Liver Cirrhosis; Male; Middle Aged; Postoperative Complications; Ribavirin; Transferrin	2005
Downregulation of glial scarring after brain injury: the effect of purine nucleoside analogue ribavirin. Annals of the New York Academy of Sciences, 2005, Volume: 1048 Topics: Animals; Astrocytes; Brain Injuries; Cerebral Cortex; Down-Regulation; Glial Fibrillary Acidic Protein; Immunohistochemistry; Postoperative Complications; Purine Nucleosides; Rats; Ribavirin; Somatosensory Cortex; Time Factors; Vimentin	2005
The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. Transplantation proceedings, 2006, Volume: 38, Issue:5 Topics: Adult; Antiviral Agents; Biopsy; Cholesterol, HDL; Disease Progression; Fatty Liver; Female; Hepatitis C; Humans; Liver Cirrhosis; Living Donors; Male; Metabolic Syndrome; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Ribavirin; Triglycerides	2006
[Prophylaxis and treatment for recurrent hepatitis C virus after liver transplantation]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2006, Volume: 103, Issue:6 Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Postoperative Complications; Recombinant Proteins; Ribavirin; Secondary Prevention; Tissue Donors	2006
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 2007, Volume: 20, Issue:7 Topics: Aged; Alanine Transaminase; Antiviral Agents; Cohort Studies; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome	2007
Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success. Journal of hepatology, 2007, Volume: 46, Issue:6 Topics: Antiviral Agents; Clinical Trials as Topic; Hepacivirus; Hepatitis C; Humans; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin	2007
[Acute hepatitis C infection: epidemiological and clinical aspects, and efficacy of interferon therapy]. Le infezioni in medicina, 2007, Volume: 15, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Colonoscopy; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Sexual Behavior; Substance Abuse, Intravenous	2007
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:7 Topics: Adult; Analysis of Variance; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Treatment Outcome	2007
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:8 Topics: Antiviral Agents; Biopsy; Bronchoscopy; Diagnosis, Differential; DNA, Viral; Female; Follow-Up Studies; Humans; Lung; Lung Transplantation; Metapneumovirus; Middle Aged; Paramyxoviridae Infections; Pneumonia, Viral; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Ribavirin	2007
Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3). Chest, 1995, Volume: 108, Issue:5 Topics: Amantadine; Antiviral Agents; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Influenza A virus; Male; Middle Aged; Muromonab-CD3; Pneumonia, Viral; Postoperative Complications; Ribavirin; Virulence	1995
Hepatitis C virus infection in renal transplantation. Transplantation proceedings, 1995, Volume: 27, Issue:2 Topics: Azathioprine; Cyclosporine; Hepatitis C; Humans; Kidney Transplantation; Liver; Pancreas Transplantation; Polymerase Chain Reaction; Postoperative Complications; Ribavirin	1995
Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients. Lancet (London, England), 1993, Apr-03, Volume: 341, Issue:8849 Topics: Aerosols; Humans; Lung Diseases; Lung Transplantation; Postoperative Complications; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin	1993
Parainfluenza virus respiratory infection after heart transplantation: successful treatment with ribavirin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:4 Topics: Antiviral Agents; Heart Transplantation; Humans; Male; Middle Aged; Paramyxoviridae Infections; Pneumonia, Viral; Postoperative Complications; Ribavirin	1995
[Therapy of recurrent hepatitis C after liver transplantation]. Praxis, 1998, Sep-02, Volume: 87, Issue:36 Topics: Combined Modality Therapy; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Pilot Projects; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin	1998
Organ-transmitted HCV infection in kidney transplant recipients from an anti-HCV negative donor. Transplantation proceedings, 1999, Volume: 31, Issue:8 Topics: Adult; Antiviral Agents; Cadaver; Child; Fatal Outcome; Female; Hepatitis C; Humans; Kidney Transplantation; Liver; Liver Function Tests; Male; Middle Aged; Postoperative Complications; Ribavirin; Tissue Donors	1999
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation proceedings, 2000, Volume: 32, Issue:4 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Treatment Outcome	2000
Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:3 Topics: Adult; Aged; Antiviral Agents; Disease Progression; Female; Granulocyte Colony-Stimulating Factor; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Viral Load	2001
Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. Transplantation, 2001, Mar-15, Volume: 71, Issue:5 Topics: Adult; Aged; Antiviral Agents; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral; Transaminases; Viral Load	2001
Successful ribavirin therapy for life-threatening laryngeal papillomatosis post liver transplantation. Pediatric transplantation, 2001, Volume: 5, Issue:2 Topics: Antiviral Agents; Child, Preschool; Female; Humans; Laryngeal Neoplasms; Liver Transplantation; Papilloma; Postoperative Complications; Ribavirin	2001
Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C. Transplantation, 2001, May-27, Volume: 71, Issue:10 Topics: Adult; Antiviral Agents; Cholestasis; Drug Therapy, Combination; Fatal Outcome; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Severity of Illness Index	2001
Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation. Transplantation proceedings, 2001, Volume: 33, Issue:6 Topics: Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Transplantation; Postoperative Complications; Retrospective Studies; Ribavirin; Time Factors	2001
Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:10 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; Statistics, Nonparametric; Treatment Outcome	2001
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:7 Topics: Adult; Aged; Anemia; Antiviral Agents; Clinical Protocols; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin	2002
Severe respiratory syncytial virus pneumonia in an adult renal transplant recipient: successful treatment with ribavirin. Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:1 Topics: Administration, Inhalation; Adult; Humans; Kidney Transplantation; Male; Pneumonia, Viral; Postoperative Complications; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides	1990
Association of parainfluenza virus type 3 infection with allograft rejection in a liver transplant recipient. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:8 Topics: Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Infant; Liver Transplantation; Parainfluenza Virus 3, Human; Paramyxoviridae Infections; Pneumonia, Viral; Postoperative Complications; Ribavirin	1989
Influenza B in transplant patients. Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:3 Topics: Adult; Bone Marrow Transplantation; Child; Female; Humans; Influenza B virus; Influenza, Human; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Ribavirin; Ribonucleosides	1989
Respiratory syncytial virus infection in immunocompromised adults. Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3 Topics: Adult; Antigens, Viral; Cross Infection; Female; Humans; Immune Tolerance; Immunosuppression Therapy; Male; Middle Aged; Opportunistic Infections; Postoperative Complications; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Serologic Tests; Transplantation	1988